VVOS: SOKOLOW LEONARD J discloses securities transactions
By AlphaYouPublished Form 4
SOKOLOW LEONARD J
Reporting filer
SOKOLOW LEONARD J reported Grant or award in Vivos Therapeutics, Inc.: 12000 units of Stock Options (Right to Buy) (derivative), dated 2026-09-14. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 19, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) (derivative) | SOKOLOW LEONARD J | 2026-09-14 | A | Grant or award | 12000 | 0 | 17,600 | 5 days | Filed terms
|
Stock Options (Right to Buy) (derivative)
- Owner
- SOKOLOW LEONARD J
- Date
- 2026-09-14
- Code
- A
- Action
- Grant or award
- Quantity
- 12000
- Price
- 0
- Following holdings
- 17,600
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Stock Options (Right to Buy)
- id: F1
- conversion Or Exercise Price: 0.18
- transaction Date: 2026-09-14
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 12000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- exercise Date: 2026-09-14
- id: F1
- expiration Date: 2036-09-14
- underlying Security Title: Common Stock
- underlying Security Shares: 12000
- shares Owned Following Transaction: 17600
- id: F1
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- SOKOLOW LEONARD J: Director.
- F1: On September 14, 2026 (the "Grant Date"), the Reporting Person received a grant of 12,000 stock options from the Issuer. One-half vested immediately (and the earliest possible exercise date in Table II relates to this tranche), one-fourth will vest on September 30, 2026 and one-fourth will vest on December 31, 2026. The options are exercisable for a period of 10 years from the Grant Date. Reflects expiry of 667 options on June 19, 2025 and 1,200 options on August 5, 2026, all of which expired unexercised.
Original sources
Prepared automatically from public filing data. Report a correction.